Stock listing
NASDAQ:ETTX Entasis Therapeutics Holdings Inc Stock
Follow Entasis Therapeutics Holdings Inc into a list and get an email when it puts out news.
Last close · NASDAQ:ETTX
$2.19 USD
Close on Jul 11, 2022 · No longer trades
- Lowest – highest close
- $1.45 – $10.88 USDSince Sep 26, 2018 · lowest Feb 1, 2022 · highest Sep 28, 2018
Delisted NASDAQ:ETTX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:ETTX
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Entasis Therapeutics Holdings Inc on 6ix
- Calls
- 2 calls with a replay · 2 with a transcript · latest Nov 4, 2021
- Decks
- 3 decks · latest Oct 19, 2021
Events
| Call | When | Status |
|---|---|---|
| Entasis Therapeutics Holdings (ETTX) Q3 2021 Earnings Call | Thu, Nov 04, 2021 · 8:00 AM ET | Replay |
| Entasis Therapeutics Holdings (ETTX) Q2 2021 Earnings Call | Thu, Aug 12, 2021 · 8:00 AM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Technical Presentation (October 2021) | Technical | 14 slides | Oct 19, 2021 |
| Investor Presentation (March 2021) | Investor deck | 42 slides | Mar 23, 2021 |
| Investor Presentation (July 2020) | Investor deck | 37 slides | Jul 23, 2020 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| James N Topper Other companies: Attovia Therapeutics, Inc. (Director · Since at least Aug 4, 2026); NewAmsterdam Pharma Company N.V. (Director · Since at least Dec 29, 2023); Phathom Pharmaceuticals, Inc. (Director · Since at least Oct 24, 2019); Frazier Lifesciences Acquisition Corp (Chief Executive Officer, Director · Dec 8, 2020 – Dec 11, 2020 · Past); Aptinyx Inc (Director · Jun 20, 2018 – Mar 31, 2020 · Past); Allena Pharmaceuticals Inc (Director · Nov 1, 2017 – Nov 17, 2020 · Past); Alpine Immune Sciences Inc (Director · Jul 24, 2017 – May 18, 2024 · Past); AnaptysBio, Inc. (Director · Jan 25, 2017 – Jan 6, 2023 · Past); Sierra Oncology Inc (Director · Jul 15, 2015 – Feb 14, 2017 · Past); Portola Pharmaceuticals Inc (Director · May 21, 2013 – Jun 5, 2013 · Past); Amicus Therapeutics Inc (Director · Jun 15, 2010 – Jun 12, 2014 · Past) | Director · Sep 25, 2018 – Jan 18, 2019 · Past |
| Heather Preston Other companies: Oxford Nanopore Technologies PLC (Non Executive Director · Since at least May 1, 2026); Aligos Therapeutics, Inc. (Director · Since at least Aug 7, 2024); Akouos Inc (Director · Jun 25, 2020 – Nov 30, 2022 · Past); Fusion Pharmaceuticals Inc (Director · Jun 25, 2020 – Jun 14, 2023 · Past); Karuna Therapeutics Inc (Director · Jun 27, 2019 – Jun 24, 2021 · Past); Albireo Pharma Inc (Director · Nov 3, 2016 – Jan 23, 2017 · Past); Otonomy Inc (Director · Aug 12, 2014 – Jun 11, 2019 · Past); Alder BioPharmaceuticals Inc (Director · May 7, 2014 – Oct 22, 2019 · Past) | Director · Sep 25, 2018 – Jun 19, 2019 · Past |
| Gregory Norden Other companies: Praxis Precision Medicines, Inc. (Director · Since at least Oct 15, 2020); Royalty Pharma plc (Director · Since at least Jun 15, 2020); Zoetis Inc. (Director · Since at least Feb 11, 2020); NanoString Technologies Inc (Director · Jun 18, 2019 – May 6, 2024 · Past) | Director · Jun 19, 2019 – Jun 19, 2019 · Past |
| David Meek Other companies: Cullinan Therapeutics, Inc. (Director · Since at least May 15, 2024); uniQure N.V. (Chairman of the Board · Since at least Feb 25, 2021); Fusion Pharmaceuticals Inc (Director · Oct 16, 2023 – Jun 4, 2024 · Past) | Director · Jun 10, 2020 – Jul 7, 2022 · Past |
| David Altarac Other companies: Innoviva, Inc. (Chief Medical Officer, IST · Since at least Oct 19, 2026) | Chief Medical Officer · Nov 4, 2019 – Jul 7, 2022 · Past |
| Heather Berger Other companies: Design Therapeutics, Inc. (Director · Since at least Jun 15, 2021) | Director · Jun 10, 2020 – Jul 7, 2022 · Past |
| Michael Gutch Other companies: Albireo Pharma Inc (Director · Nov 3, 2016 – Mar 2, 2023 · Past) | See Remarks · Sep 25, 2018 – Jan 18, 2022 · Past |
| Anna Diaz Triola | Chief Commercial Officer · Jul 19, 2021 – Jul 11, 2022 · Past |
| John Patrick Mueller | Chief Development Officer · Jul 7, 2022 – Jul 7, 2022 · Past |
| Kristie Ann Wagner | VP, Principal Fin & Acct Off · Feb 24, 2022 – Jul 11, 2022 · Past |
All 11 people
| Person | Seat |
|---|---|
| Manoussos Perros | President and CEO, Director · Sep 25, 2018 – Jul 7, 2022 · Past |
Log in to ask 6ix AI your own questions about Entasis Therapeutics Holdings Inc.